Screenin3D is a company that develops microfluidic technology for cancer therapy assessment, enabling the testing of CAR-T cells and combination therapy on miniaturized solid cancer models.

Screenin3D

Precision medicine and drug development based on maximising screening of limited human cancerous tissue in 3D with microfluidic technology.

ScreenIn3D

ScreenIn3D is getting ready to attend the Next Gen Organ-on-Chip & Organoids workshop organized by CSEM in Zurich on August 24-25th!

A fantastic venue to meet #clinicians, #scientists, #researchers and decision makers from the #pharma & #biotech industry and share the latest breakthroughs in #OrganOnChip.
 
We are delighted to contribute to the exciting scientific program with a talk from our CEO, Michele Zagnoni, who will be showcasing our tumour-on-a-chip platform for precision oncology. We hope to see you there at 4:50pm on day 1.
 
#OrganOnChip #Organoids #CSEM #Research #TumourOnAChip

Metric
Company Name	Screenin3D
Symbol
MSH ID	COM:SCREENIN3D
Market	PRIVATE
Sector	9
Industry	Healthcare & Health Services
Country	GB
Stage
Employee Count	4
Website	screenin3d.com
LinkedIn	screenin3d
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SCREENIN3D

Screenin3D

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue